CEL-SCI Corporation Reports Third Quarter Fiscal 2023 Financial Results

CEL-SCI Corporation today reported financial results for the quarter ended June 30, 2023, as well as key clinical and corporate developments.


Clinical and Corporate Developments this quarter...

Related Keywords

Baltimore ,Maryland ,United States ,Virginia ,Vienna ,Wien ,Austria ,Canada ,American ,Geert Kersten ,Health Canada ,European Society For Radiotherapy ,Securities Exchange ,Drug Administration ,Neck Cancer Society ,International Conference On Head ,Exchange Commission ,Corporate Developments ,American Head ,Annual International Conference ,Neck Cancer ,Leukocyte Interleukin Injection ,European Society ,Leukocyte Interleukin ,Orphan Drug ,Securities Act ,Securities Exchange Act ,